This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.
The analysis included health information from 273,260 female participants in the United Kingdom Biobank, and the findings suggest that those who start their period younger and go […]
Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.
The short answer is that all Biobanks are Biorepositories, but not all Biorepositories are Biobanks. Realistically speaking, the terms “Biobank” and “Biorepository” are used pretty interchangeably. The differences we can point out when someone asks: What is the difference between Biobanks and Biorepositories?
Researchers have used proteomics data from the UK Biobank to identify protein biomarkers in blood that could give warning of dementia years before diagnosis
Generation of strong research dataset cohorts must begin with high-quality clinical samples. Biobanks are used for the coordination of high-yield patient sample collection. The webinar highlighted the importance of maximizing utility and sustainability for the long-term success of biorepositories and biobanks.
UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific researchers, taking on some of the responsibility held by GPs.
The RNA interference specialist says its researchers and collaborators have identified mutations in a gene called INHBE that are associated with protection against abdominal obesity and metabolic syndrome – a condition impacting more than 20% of adults worldwide. Image by Bruno /Germany from Pixabay .
Poor quality sleep may bolster a person's genetic susceptibility to asthma, potentially doubling their risk of being diagnosed with the condition, suggests a large UK Biobank study, published in BMJ Open Respiratory Research.
An international team of medical researchers has found a link between major depressive disorder (MDD) and an interplay between the gut microbiome and the blood metabolome. For their study, reported in the journal JAMA Psychiatry, the group analyzed data in the UK Biobank.
The idea of ‘genetic superheroes’ and precision medicine is captivating for researchers, but the concept can be abstract and distant for participants. In our experience of running 20+ precision medicine studies, there are a few design principles that every research programme – from biobanks to clinical trials – should consider.
An Academy of Finland Academy Programme, Health from Cohorts and Biobanks (COHORT), has become a global forerunner in the collaborative use of existing research data. Over the past two decades, Finnish research on health promotion has reached a very high level in global terms.
The new AIID building will include a human infection challenge unit, high-containment facilities, a robotic biobanking facility, interview rooms, dry laboratories and spaces for community engagement and co-design work. It will be connected across multiple levels to the University of Melbourne’s Doherty Institute.
Researchers at the Francis Crick Institute and University College London in the UK have found how air pollution can trigger the activation of cells with existing genetic mutations to form cancer. The researchers propose that particulate matter 2.5 The new research shows that air pollutants can be that ‘second hit.’
Researchers have analyzed image and genomic data from the UK Biobank to find insights into rare diseases of the human eye. These include retinal dystrophies—a group of inherited disorders affecting the retina—which are also the leading cause of blindness certification in working-age adults.
A team of researchers affiliated with several institutions in Alabama has linked 10 genetic loci to the development of osteoarthritis. and the UK Biobank in the U.K. In their paper published in the journal Nature Genetics, the group describes their analysis of data from the Million Veteran Program in the U.S.
Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobankresearch participants. (Nasdaq: BIIB) and Pfizer (NYSE: PFE). These genetic data have been paired with detailed health information to create this browsable resource.
We need human tissues and cells for biomedical research. Biosamples and biomarkers are the core basis for much of the work done in the clinical research industry and proficient Human Biosample Management (HBSM) is necessary to procure reliable biosamples. Automated Biobanking. Sample Backup.
The need for sharing information across the medical research landscape was never starker than during the early days of the COVID-19 pandemic. According to Nature Biotechnology, “81% of researchers are constrained by the inadequate quantity and quality of biospecimens and 80% of companies find accessing materials difficult.”.
In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250 In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental (..)
Researchers from the group of Hans Clevers in collaboration with the group of Bart Haagmans (Erasmus MC) established an organoid biobank to search for the genes that are essential for the spreading of a SARS-CoV2 infection.
AstraZeneca scientists, based in Cambridge UK, have analysed over 18,000 phenotypes in combination with whole exome sequencing data from nearly 300,000 UK Biobankresearch participants.
to build a scalable data, analytics, and infrastructure platform This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine. Boehringer Ingelheim partners with Lifebit Biotech, Ltd.
Oxford vice chancellor Prof Louise Richardson said the “unique partnership” would see staff from the Nuffield and GSK “working side-by-side to research and develop treatments for some of the most difficult to treat diseases.” ” The post GSK pumps £30m into a new Oxford University partnership appeared first on.
Both long- and short-read sequencing today is faster, more affordable, and highly accurate, providing researchers with deep insights to fuel research. Moreover, research has shown that genetic testing can reduce adverse reactions to drugs by nearly one third. Just one mutation can lead to a complete change in protein formation.
By participating, you can help researchers uncover crucial insights that could lead to better, more effective therapies for AD. Join this research study to potentially improve the future treatment and care of those living with atopic dermatitis. Participants will be helping to advance medical research. Why Participate?
One of the reasons is because researchers now have far more genetic data to work with than was ever previously possible. With such a drop in cost, this means that researchers can test far more often and work with far more genetic data than previously possible.
New research published in the Journal of Bone and Mineral Research has linked heavier birth weight with lower bone mineral density and a higher risk of bone fracture later in life.
More Study Details About the Research Centre Location Research Centre: Monash Alfred Psychiatry Research Centre (MAPrc) Location: Level 4, 607 St Kilda Rd., Participants will be helping to advance medical research. Contents About the Study Why Participate? Your Rights Who Can Participate? But there’s hope!
Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobankresearch participants. (Nasdaq: BIIB) and Pfizer (NYSE: PFE). These genetic data have been paired with detailed health information to create this browsable resource.
Lifebit’s mission is to revolutionise bioinformatics and biomedical data analysis by bringing together biobanks from across the globe to create an “access portal to the world’s clinico-genomic data,” Dunford says.
The new database, COVID-19 Neuro Databank/Biobank (NeuroCOVID), will be maintained by NYU Langone Health in New York City. MONDAY, Feb. The database will collect information on COVID-19-related neurological symptoms, complications, and outcomes, as well as COVID-19 effects on preexisting neurological conditions. ” More Information.
17 in Cancer Research. Biobank, born between 1939 and 1970, to clarify the time-dependent effects between long-term oral contraceptive use and cancer risk. Biobank, born between 1939 and 1970, to clarify the time-dependent effects between long-term oral contraceptive use and cancer risk. MONDAY, Dec. Torgny Karlsson, Ph.D.,
Biobank participants, with adjustment for major confounding variables. The researchers found that “permanent” night shift workers had an increased likelihood of moderate-severe asthma and all asthma compared with day workers (odds ratios, 1.36 Robert Maidstone, Ph.D., and 1.23, respectively).
Chinook will have access to the NURTuRE cohort study along with other proprietary patient biobanks and Evotec’s multi-omics integration platform, and the company plans to potentially deliver targeted therapies in rare kidney diseases such as IgA nephropathy and glomerular diseases.
Biobank that enrolled more than 500,000 Britons aged 40 to 69 years from 2006 to 2010. The researchers found that each additional standard deviation of the smoking polygenic risk score was associated with a significantly increased risk for smoking (odds ratio, 1.21) and with a significantly increased SAH risk (odds ratio, 1.10).
George Freeman, minister for science, research and innovation at the Department for Business, Energy and Industrial Strategy, opened proceedings by reminding us of some of the UK’s recent achievements and aspirations for the future. Faster access for patients for interventions. Data on all aspects, including stratification of patient types.
Bayer is progressing novel research around its prostate cancer treatment darolutamide. Both small molecule inhibitors in Immuno-Oncology are being jointly developed in a strategic research alliance with the German Cancer Research Center (DKFZ) in Heidelberg, Germany.
Is it now stored in a biobank? If a sample source has been verified you can make it available for research associates (RAs) to start testing right away. Anything that happened to the sample is only a few button clicks away. Is the sample being transported? Has it been scanned and verified? Has it been deployed to a project?
Borja Ibáñez, group leader of the Translational Laboratory for Cardiovascular Imaging and Therapy at the CNIC, cardiologist at the Hospital Universitario Fundación Jiménez Díaz (FJD) in Madird, and member of the CIBERCV cardiovascular research network. The study is a prime example of collaboration between basic and clinical researchers.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content